4-methoxyamphetamine has been researched along with amiodarone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Badilini, F; Benchetrit, C; Coumel, P; Leenhardt, A; Maisonblanche, P; Milliez, P; Siliste, C; Vicaut, E | 1 |
Aiba, T; Aihara, N; Kamakura, S; Kurita, T; Noda, T; Okamura, H; Satomi, K; Shimizu, W; Suyama, K; Taguchi, A; Yamagata, K | 1 |
Brunetti, L; Bucek, J; Kim, D; Kim, OK; Lee, SM; Miao, B; Nahass, RG; Suh, D; Suh, DC | 1 |
1 trial(s) available for 4-methoxyamphetamine and amiodarone
Article | Year |
---|---|
Electrophysiologic study-guided amiodarone for sustained ventricular tachyarrhythmias associated with structural heart diseases.
Topics: Aged; Amiodarone; Death; Electrocardiography, Ambulatory; Electrophysiologic Techniques, Cardiac; Female; Heart Diseases; Humans; Male; Middle Aged; Recurrence; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome | 2008 |
2 other study(ies) available for 4-methoxyamphetamine and amiodarone
Article | Year |
---|---|
Usefulness of ventricular repolarization dynamicity in predicting arrhythmic deaths in patients with ischemic cardiomyopathy (from the European Myocardial Infarct Amiodarone Trial).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Death; Electrocardiography, Ambulatory; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Predictive Value of Tests; Stroke Volume; Ventricular Dysfunction | 2005 |
The risk of cardiac events in patients who received concomitant levofloxacin and amiodarone.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Body Mass Index; Death; Drug Therapy, Combination; Electrocardiography; Female; Hospitalization; Humans; Levofloxacin; Logistic Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Treatment Outcome | 2019 |